PREPARATION AND CHARACTERIZATION OF METFORMIN LOADED STEARIC ACID COUPLED F127 NANOPARTICLES
Open Access
- 7 August 2018
- journal article
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- Vol. 11 (8) , 212-217
Abstract
Objective: The objective of this study was to prepare and evaluate metformin nanoparticles (MN) using stearic acid-coupled F127 (SAF127) copolymer and polyvinyl alcohol by emulsion solvent evaporation technique.Method: Metformin is the first-line drug for the treatment of type II diabetes mellitus belongs to Biopharmaceutical Classification System Class III. The prepared MN was characterized for particle size, polydispersity index (PDI), zeta potential, drug entrapment, percentage yield, in vitro drug release, and stability studies. The compatibility studies were performed by Fourier transform infrared (FTIR) and differential scanning calorimetry (DSC). The crystallographic and surface properties were studied by X-ray diffractometry and scanning electron microscopy, respectively.Results: The mean particle diameter of prepared nanoparticles ranged from 207.8 to 977.64 nm, PDI value ranged from 0.146 to 0.694, and zeta potential ranged from −20.5 to −6.97 mV. The drug entrapment efficiency of these nanoparticles varies between 18.81 to 69.01 %. The drug to SAF127 copolymer (10/30 w/w) ratio (MN3) showed optimum results. The MN3 had spherical morphology with semi-amorphous nature. The results of FTIR and DSC analysis showed that there was no significant interaction between drug and excipients. The prepared polymeric nanoparticles were stable at 5±3°C up to 3 months. In vitro release of drug from MN3 was 20.52% in the first 1 h and remaining drug was released up to 30 h.Conclusion: The results of this study confirmed the sustained drug release profile of metformin loaded SAF127 copolymer nanoparticles. These nanoparticles can be best stored up to 3 months.Keywords
This publication has 19 references indexed in Scilit:
- The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cellsJournal of Drug Delivery Science and Technology, 2018
- Controlled release of metformin from chitosan–based nanocomposite films containing mesoporous MCM-41 nanoparticles as novel drug delivery systemsJournal of Colloid and Interface Science, 2017
- Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic ratsEuropean Journal of Pharmaceutical Sciences, 2017
- Enhancing bioavailability and controlling the release of glibenclamide from optimized solid lipid nanoparticlesJournal of Drug Delivery Science and Technology, 2017
- In Vitro and In Vivo Biological Evaluation of O-Carboxymethyl Chitosan Encapsulated Metformin Nanoparticles for Pancreatic Cancer TherapyPharmaceutical Research, 2014
- Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugsInternational Journal of Pharmaceutics, 2013
- Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicineColloids and Surfaces B: Biointerfaces, 2013
- Synthesis and characterization of novel amphiphilic copolymer stearic acid-coupled F127 nanoparticles for nano-technology based drug delivery systemColloids and Surfaces B: Biointerfaces, 2011
- Influence of processing variables and in vitro characterization of glipizide loaded biodegradable nanoparticlesDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2009
- Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pelletsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006